Oculis Holding AG (OCS) Receivables - Other (2021 - 2025)
Oculis Holding AG (OCS) recorded quarterly Receivables - Other of $13.3 million in Q4 2025, up 305.86% quarter-over-quarter from $3.3 million in Q4 2024, and up 305.86% on a YoY basis from $3.3 million in Q4 2024.
Oculis Holding AG (OCS) Receivables - Other (2021 - 2025) Analysis & Trends
Oculis Holding AG's Receivables - Other history runs 5 years deep, the most recent figure standing at $13.3 million for Q4 2025.
- In Q4 2025, Receivables - Other rose 305.86% year-over-year to $13.3 million; the TTM figure through Dec 2025 stood at $13.3 million (up 305.86% YoY), while the FY2025 annual figure was $13.3 million, up 305.86% from the prior year.
- Receivables - Other was $13.3 million for Q4 2025 at Oculis Holding AG, up from $3.3 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $13.3 million in Q4 2025 to a low of $1038.0 in Q4 2022.
- Historically, Receivables - Other has averaged $3.8 million across 5 years, with a median of $2.4 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Receivables - Other slipped 4.29% in 2022, then soared 232859.95% in 2023.
- A 5-year view of Receivables - Other shows it stood at $1084.5 in 2021, then decreased by 4.29% to $1038.0 in 2022, then jumped by 232859.95% to $2.4 million in 2023, then surged by 35.86% to $3.3 million in 2024, then surged by 305.86% to $13.3 million in 2025.
- The last three Receivables - Other figures came in at $13.3 million (Q4 2025), $3.3 million (Q4 2024), and $2.4 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.33 Mn |
| Dec 31, 2025 | 13.33 Mn |
| Dec 31, 2024 | 3.29 Mn |
| Dec 31, 2024 | 3.29 Mn |
| Dec 31, 2023 | 2.42 Mn |
| Dec 31, 2023 | 2.42 Mn |
| Dec 31, 2022 | 1,038.02 |
| Dec 31, 2022 | 1,038.02 |
| Dec 31, 2021 | 1,084.50 |
| Dec 31, 2021 | 1,084.50 |